Non Tariff Measures as a Policy Measure: an Analysis of India-EU Trade in Pharmaceutical Sector

International Journal of Economics and Management Studies

© 2018 by SSRG - IJEMS Journal

Volume 5 Issue 4

Year of Publication : 2018

Authors : Rakhi Singh, Dr.Seema Sharma

10.14445/23939125/IJEMS-V5I4P102

How to Cite?

Rakhi Singh, Dr.Seema Sharma, "Non Tariff Measures as a Policy Measure: an Analysis of India-EU Trade in Pharmaceutical Sector," SSRG International Journal of Economics and Management Studies, vol. 5,  no. 4, pp. 9-13, 2018. Crossref, https://doi.org/10.14445/23939125/IJEMS-V5I4P102

Abstract:

 The purpose of this paper is to analyse trade in pharmaceutical sector between India and EU with respect to the Non-Tariff Barriers as policy measures. The paper studies about India as a significant player in global generic market and the incentives to use the non tariff barriers. The paper focuses extensively on EU’s non tariff barriers with other partners, especially India. The study relies on the secondary data on trade in pharmaceutical sector between India and EU. Pharmaceutical sector is a big enough market for an open warfare among existing and new players looking for growth opportunities. Companies looking to protect their turfs in erstwhile protected markets will look to retain their markets by launching cheaper versions of their patented products. At the same time new players will look for these opportunities of growth. A good indicator of a country’s external engagements is whether its foreign and trade policies reinforce each other. The paper shows that in case of very high non tariff barriers, better option for the companies would be to protect their interest by other means.

Keywords:

  Non-Tariff Barriers/Measures, Global Pharmaceutical Market, Import Elasticity, Per capita GDP, Exports to EU.

References:

1) Antimiani, A. and Salvatici, L., 2005. EU trade policies: benchmarking protection in a general 
2) equilibrium framework, ETSG Dublin, 7th Annual Conference, University College Dublin 
3) Hanson, D., 2010. Limits to Free Trade: Non-Tariff Barriers in the European Union, Japan 
4) and United States, Edward Elgar Publishing Ltd 
5) Mehta, R., 2005. Non Tariff Barriers Affecting India's Exports, Final Technical paper on NTB 
6) (2009) Pharma MNCs want to Take a Shot at India’s Vaccine Market, Economic Times. 
7) Joseph, R. K., (2008) The Ranbaxy model and consolidation in pharma sector, The EconomicTimes 24 
8) Priya, S.,and Joseph, Reji K., 2009 Review of Trade Policies of India’s Major Trading Partners. Available at RN: https://ssrn.com/abstract=1282010 or http://dx.doi.org/10.2139/ssrn.1282010 
9) ASA & Associates, 2015, A Brief Report on Pharmaceutical Industry in India. Retrieved from file:///C:/Users/Rakhi%20Singh/Downloads/Pharmaceutical-Industry-in-India.pdf 
10) https://www.gov.uk/apply-for-a-licence-to-market-a-medicine-in-the-uk 
11) https://www.gov.uk/guidance/apply-for-manufacturer-or-wholesaler-of-medicines-licences 
12) Indian Pharma Export Numbers.pdf 
13) http://www.ibef.org/industry/pharmaceutical-india.aspx 
14) http://commerce.nic.in/pressrelease/pressrelease_detail.asp?id=2720 
15) http://ec.europa.eu/trade/policy/countries-and-regions/countries/india/ 
16) http://www.eac.int/customs/component/content/article/56/56.html